References
- LiJWangYZhuYRecent advances in delivery of drug-nucleic acid combinations for cancer treatmentJ Control Release2013172258960023624358
- TsourisVJooMKKimSHNano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancersBiotechnol Adv20143251037105024924617
- ResnierPMontierTMathieuVA review of the current status of siRNA nanomedicines in the treatment of cancerBiomaterials201334276429644323727262
- OhYKParkTGsiRNA delivery systems for cancer treatmentAdv Drug Delivery Rev20096110850862
- CostaPMCardosoALCustodiaCMiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastomaJ Control Release2015207313925861727
- KatoTNatsumeATodaHEfficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cellsGene Ther201017111363137120520650
- WangMLuXDongXpERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expressionWorld J Surg Oncol20151316625880226
- MendonçaLSMoreiraJNde LimaMCPCo-encapsulation of anti-BCR-ABL siRNA and imatinib mesylate in transferrin receptor-targeted sterically stabilized liposomes for chronic myeloid leukemia treatmentBiotechnol Bioeng2010107588489320632368
- ChenJSheuAYLiWGPoly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumorsJ Control Release2014184101724727059
- LiJ-MWangY-YZhaoM-XMultifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time trackingBiomaterials20123392780279022243797
- BozzutoGMolinariALiposomes as nanomedical devicesInt J Nanomedicine20151097599925678787
- MovahediFHuRGBeckerDLStimuli-responsive liposomes for the delivery of nucleic acid therapeuticsNanomedicine20151161575158425819885
- ChenZHanLXuMRationally designed multitarget anticancer agentsCurr Med Chem201320131694171423410168
- LiuJBoonkaewBAroraJComparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinomaJ Pharm Sci201510431187119625573425
- ZhangHZhangFMYanSJPreparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticlesInt J Nanomedicine201272901291022787390
- CaoHQWangYXHeXYCodelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinomaMol Pharm201512392293125622075
- ShenJSunHMengQSimultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNAMol Pharm201411103342335124495194
- WangJLXiYLiuYLCombination of targeted PDT and anti-VEGF therapy for rat CNV by RGD-modified liposomal photocyanine and sorafenibInvest Ophthalmol Vis Sci201354137983798924204046
- WangLGengDSuHSafe and efficient pH sensitive tumor targeting modified liposomes with minimal cytotoxicityColloids Surf B Biointerfaces201412339540225438693
- HardiansyahAHuangLYYangMCNovel pH-sensitive drug carriers of carboxymethyl-hexanoyl chitosan (Chitosonic (R) Acid) modified liposomesRsc Advances20155302313423143
- MouryaVInamdarNNTiwariACarboxymethyl chitosan and its applicationsAdv Mat Lett2010111133
- LiuFXLiMLiuCXpH-Sensitive self-assembled carboxymethyl chitosan-modified DNA/polyethylenimine complexes for efficient gene deliveryJ Biomed Nanotechnol201410113397340626000398
- LiuTWangMWangTCo-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrierColloids Surf B Biointerfaces201512653154025618822
- WangMFLiuTXHanLQFunctionalized O-carboxymethyl-chitosan/polyethylenimine based novel dual pH-responsive nanocarriers for controlled co-delivery of DOX and genesPolymer Chemistry201561733243335
- FengQYuMZWangJCSynergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticlesBiomaterials201435185028503824680191
- ChenWYuanYChengDCo-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapySmall201410132678268724668891
- LiuYFengLLiuTMultifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancerNanoscale2014663231324224500240
- DengZJMortonSWBen-AkivaELayer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatmentAcs Nano20137119571958424144228
- DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesJ Control Release201418713314424874289
- WangFChenLZhangRRGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancerJ Control Release201419622223325456829
- QuM-HZengR-FFangSLiposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancerInt J Pharm2014474111212225138252
- FanYSahdevPOchylLJCationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigensJ Control Release201520812112925869965